Klick Health

Global HCP insights from Manhattan Research (DRG)

Editor

in
Read More

It's always good to sign up for Manhattan Research webinars even if you can't attend because you'll get a reminder about the presentation afterward. This deck was from their webinar titled "Best practices for global physician engagement and tailoring programs by country."

The stats are from Ex-US locations but are interesting nonetheless.

Three main themes emerge from the teaser report:

Here are some selected charts from the DRG teaser report. Grab your own copy to get the whole story.

HCPs visit pharma sites

75% of HCPs in Brazil visit pharma sites for specific product information. 66% (approx.) in Canada and Australia do the same. The main content HCPs want to see on these sites is:Patient tools

The HCPs that said they would visit pharma sites more frequently if it was easier to access and share resources for patients:

The numbers of HCPs who said they wanted to find tools (digital and paper-based) to help track adherence:Sponsored content

Sponsored content gets a surprisingly warm reception from HCPs when its found on their favorite HCP websites (such as Medscape). The numbers who said they are interested in accessing this information:

Those that said they visited a pharma property after seeing this information are substantial (I’m reading the blue as visited -Ed.):That’s a long Wire story but worth it. The full report is downloadable from the Manhattan Research (DRG) website.

Source: Manhattan Research (DRG)

More About the Author

Klick Wire

This is the Klick Wire blog account. Here you will find archived versions of all your favorite Klick Wire stories. To get these stories delivered to your inbox every week, use the sign up form at the bottom of this page.

More from this author

Go from news to action. Klick Wire

Weekly Digital Health Newsletter

Klick Health will NEVER spam you. Read our privacy policy

Thank you! You're now signed up to get the Klick Wire every week - news from the world of digital health marketing.

Sorry there seems to be a problem. Please try again later.